| Product Code: ETC11505486 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India car-t cell therapy market import shipment exhibited a negative CAGR from 2020 to 2024. Notably, the growth rate between 2023 and 2024 experienced a significant decline. The market demonstrated a clear slowdown and contraction during this period, indicating challenges in market expansion and a need for strategic interventions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India CAR-T Cell Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India CAR-T Cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India CAR-T Cell Therapy Market - Industry Life Cycle |
3.4 India CAR-T Cell Therapy Market - Porter's Five Forces |
3.5 India CAR-T Cell Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 India CAR-T Cell Therapy Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F |
3.7 India CAR-T Cell Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India CAR-T Cell Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India CAR-T Cell Therapy Market Revenues & Volume Share, By Administration Mode, 2021 & 2031F |
4 India CAR-T Cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in India |
4.2.2 Increasing investments in healthcare infrastructure |
4.2.3 Rising awareness about personalized medicine and advanced therapies |
4.3 Market Restraints |
4.3.1 High cost associated with CAR-T cell therapy |
4.3.2 Limited availability of skilled healthcare professionals |
4.3.3 Regulatory challenges and approval process for advanced therapies |
5 India CAR-T Cell Therapy Market Trends |
6 India CAR-T Cell Therapy Market, By Types |
6.1 India CAR-T Cell Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 India CAR-T Cell Therapy Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 India CAR-T Cell Therapy Market Revenues & Volume, By Autologous CAR-T, 2021 - 2031F |
6.1.4 India CAR-T Cell Therapy Market Revenues & Volume, By Allogeneic CAR-T, 2021 - 2031F |
6.1.5 India CAR-T Cell Therapy Market Revenues & Volume, By Universal CAR-T, 2021 - 2031F |
6.1.6 India CAR-T Cell Therapy Market Revenues & Volume, By Multi-Specific CAR-T, 2021 - 2031F |
6.2 India CAR-T Cell Therapy Market, By Target Antigen |
6.2.1 Overview and Analysis |
6.2.2 India CAR-T Cell Therapy Market Revenues & Volume, By CD19, 2021 - 2031F |
6.2.3 India CAR-T Cell Therapy Market Revenues & Volume, By BCMA, 2021 - 2031F |
6.2.4 India CAR-T Cell Therapy Market Revenues & Volume, By CD22, 2021 - 2031F |
6.2.5 India CAR-T Cell Therapy Market Revenues & Volume, By HER2, 2021 - 2031F |
6.3 India CAR-T Cell Therapy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India CAR-T Cell Therapy Market Revenues & Volume, By Hematologic Cancers, 2021 - 2031F |
6.3.3 India CAR-T Cell Therapy Market Revenues & Volume, By Solid Tumors, 2021 - 2031F |
6.3.4 India CAR-T Cell Therapy Market Revenues & Volume, By Neuroblastoma, 2021 - 2031F |
6.3.5 India CAR-T Cell Therapy Market Revenues & Volume, By Lymphoma, 2021 - 2031F |
6.4 India CAR-T Cell Therapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India CAR-T Cell Therapy Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India CAR-T Cell Therapy Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 India CAR-T Cell Therapy Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.5 India CAR-T Cell Therapy Market Revenues & Volume, By Biotech Firms, 2021 - 2031F |
6.5 India CAR-T Cell Therapy Market, By Administration Mode |
6.5.1 Overview and Analysis |
6.5.2 India CAR-T Cell Therapy Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 India CAR-T Cell Therapy Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.5.4 India CAR-T Cell Therapy Market Revenues & Volume, By Gene-Modified, 2021 - 2031F |
6.5.5 India CAR-T Cell Therapy Market Revenues & Volume, By CRISPR-Enhanced, 2021 - 2031F |
7 India CAR-T Cell Therapy Market Import-Export Trade Statistics |
7.1 India CAR-T Cell Therapy Market Export to Major Countries |
7.2 India CAR-T Cell Therapy Market Imports from Major Countries |
8 India CAR-T Cell Therapy Market Key Performance Indicators |
8.1 Average turnaround time for CAR-T cell therapy treatment |
8.2 Patient satisfaction and outcomes post CAR-T cell therapy |
8.3 Number of clinical trials and research studies conducted in India on CAR-T cell therapy |
8.4 Adoption rate of CAR-T cell therapy among healthcare providers |
8.5 Number of partnerships and collaborations between pharmaceutical companies and healthcare institutions for CAR-T cell therapy research and development. |
9 India CAR-T Cell Therapy Market - Opportunity Assessment |
9.1 India CAR-T Cell Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 India CAR-T Cell Therapy Market Opportunity Assessment, By Target Antigen, 2021 & 2031F |
9.3 India CAR-T Cell Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India CAR-T Cell Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India CAR-T Cell Therapy Market Opportunity Assessment, By Administration Mode, 2021 & 2031F |
10 India CAR-T Cell Therapy Market - Competitive Landscape |
10.1 India CAR-T Cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 India CAR-T Cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here